SEATTLE and SAN FRANCISCO — NanoString Technologies, Inc, a provider of life science tools for translational research and molecular diagnostic products, today announced the global commercial launch of the nCounter Elements™ General Purpose Reagents (GPRs), a solution that enables clinical laboratories to independently develop multiplexed genomic assays and then rapidly translate those assays into clinical […]
Westlake, OH. GenomOncology and Vanderbilt-Ingram Cancer Center (VICC) today announced a partnership for the exclusive commercial development of a decision support tool based on My Cancer Genome™, an online precision cancer medicine knowledge resource for physicians, patients, caregivers and researchers. Through this collaboration, GenomOncology and VICC will enhance My Cancer Genome through the development of […]
SOUTH SAN FRANCISCO, Calif.– Fluxion Biosciences, Inc. announced a new capability to include full-service clinical sample procurement that will expand Fluxion’s IsoFlux Discovery Services offering. Fluxion currently offers a broad range of analytical services using its IsoFlux System for circulating tumor cell (CTC) enrichment, including qPCR and next-generation sequencing (NGS) based assays. With this new […]
BILLERICA, Mass — RainDance Technologies, Inc., an innovative genomics tools company ‘democratizing’ molecular testing of complex diseases, today announced that it has developed a comprehensive next-generation sequencing (NGS) panel for profiling actionable cancer mutations, enabling researchers to rapidly and cost-effectively analyze precious biopsy specimens. The ThunderBolts™ Cancer Panel targets 49 known cancer genes, including tumor […]
Ann Arbor, MI — Rubicon Genomics, Inc. today announced the launch of its PicoPLEX™ DNA-seq Kits for use with Illumina next-generation sequencing (NGS) platforms. PicoPLEX’s outstanding robustness and reproducibility have made it the worldwide standard for single-cell DNA amplification for microarray and PCR-based pre-implantation genetic screening and diagnosis. PicoPLEX DNA-seq now enables researchers and clinicians […]
Franklin Lakes, NJ -– BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global technology company, today announced the appointment of Amit Bhalla as Vice President, Global Strategy and Development. Mr. Bhalla will join BD in March, 2014 and will report to Vincent A. Forlenza, Chairman, Chief Executive Officer and President. “I am pleased to welcome […]
Minneapolis — Techne Corporation announces the appointment of James T. Hippel as Chief Financial Officer (CFO) effective April 1, 2014. Mr. Hippel is a finance executive with experience in several globally diverse technology businesses, including extensive experience with mergers, acquisitions, and operations integration. Mr. Hippel replaces Greg Melsen who resigned effective February 3, 2014 and […]
Westlake, OH. GenomOncology announced today that CompanionDx™ has selected the company’s GO Clinical Workbench™ to launch a series of next generation sequencing (NGS)-based assays related to cancer. CompanionDx™ will leverage GenomOncology’s GO Clinical Workbench™ to manage the entire workflow: from raw sequencing data through delivery of an actionable clinical report to the client. CompanionDx™ is […]
GenCell Biosystems has signed an agreement with the Fiocruz Public Health Foundation and the Institute of Molecular Biology of Paraná (IBMP) in Brazil to partner in the development of new clinical screening systems to address Brazilian Ministry of Health needs. The systems will use GenCell’s patented genetic analysis technologies and perform IVD diagnostics across a […]
GERMANTOWN, Maryland, and HILDEN, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced plans to roll out a portfolio of assays for the QIAsymphony platform to aid in the diagnosis of healthcare-associated infections. The first new test the artus C. difficile QS-RGQ MDx Kit has been submitted to the U.S. Food and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
